AI-generated summary
This review discusses fractional photothermolysis, a laser approach, as a possible treatment for melasma, a difficult-to-treat facial hypermelanosis. The authors report that the literature and their own experience show definite potential, but there are few studies and its value cannot yet be estimated. They call for systematic studies and caution against the enthusiasm seen in some publications.
- Who or what was studied
- Patients with melasma (chloasma), a common acquired hypermelanosis of the face and neck
- Limits stated in the abstract
- The authors state that there are few studies on fractional photothermolysis in melasma, so its value cannot presently be estimated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.